ï»¿<body>
	<style type="text/css">
		.csDABBDD4D{text-align:left;text-indent:0pt;margin:0pt 0pt 8pt 0pt;line-height:1.1583333}
		.csE2E98FDF{color:#000000;background-color:transparent;font-family:'Microsoft Sans Serif';font-size:12pt;font-weight:normal;font-style:normal;}
		.cs5AA6C567{color:#000000;background-color:transparent;font-family:'Microsoft Sans Serif';font-size:12pt;font-weight:normal;font-style:normal;text-decoration: underline;}
	</style>
	<p class="csDABBDD4D"><span class="csE2E98FDF">HB3167 HFA Williams 3-28</span></p><p class="csDABBDD4D"><span class="csE2E98FDF">Altizer &ndash; 3259</span></p><p class="csDABBDD4D"><span class="csE2E98FDF">	Delegate Williams moves to amend Com Sub for HB3167 on page 2, section 611, line 18, following the period by inserting a new subsection to read as follows:</span></p><p class="csDABBDD4D"><span class="csE2E98FDF">	</span><span class="cs5AA6C567">&ldquo;(f) &nbsp;At any point after an allegation is made, prior to the filing of a petition pursuant to &sect;49-4-601 of the code, the respondent may rebut a positive drug result by submitting to a 12 panel hair follicle drug test.&rdquo;</span></p></body>
